InvestorsHub Logo
Followers 28
Posts 2446
Boards Moderated 0
Alias Born 11/22/2010

Re: None

Monday, 08/27/2018 10:38:01 AM

Monday, August 27, 2018 10:38:01 AM

Post# of 124
Bank of America Initiates with $13pt

Paratek Pharmaceuticals (NASDAQ:PRTK) initiated with Neutral rating and $13 (25% upside) price target at BofA/Merrill Lynch citing challenges in driving omadacycline sales above $300M if it commercializes on its own.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRTK News